We don't cover AGLE, and we'd rather say so than guess.

Aeglea BioTherapeutics, Inc. (AGLE) is a $49M-cap name with thin filing history and little wire coverage. There isn't enough source material to explain a move honestly — and an explanation we can't source is worse than none.

WHAT WE DO HAVE

LAST PRICE

12.01

+6.7%

SOURCES FOUND

0

nothing to read

COVERAGE FLOOR

$2.0B

or a daily mover

TRY A COVERED NAME

TODAY'S MOVERS CALENDAR

DID YOU MEAN

MAGLE.STMagle Chemoswed Holding AB (publ)—EAGLE.HEEagle Filters Group Oyj—

Small caps with no filings and no coverage produce bad explanations. Drawing the line publicly is the point — it's how you know every other answer here means something.